3-hydroxyphenyltrimethylammonium and Abnormalities, Autosome

3-hydroxyphenyltrimethylammonium has been researched along with Abnormalities, Autosome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Agostini, A; Carella, M; Cimarosto, L; Cunsolo, CL; Hernández-Rivas, JM; Hernández-Sánchez, M; Palumbo, O; Palumbo, P; Solimando, AG; Storlazzi, CT; Tolomeo, D	1

Other Studies

1 other study(ies) available for 3-hydroxyphenyltrimethylammonium and Abnormalities, Autosome

Article	Year
A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions. Cancer genetics, 2023, Volume: 272-273 Topics: Chromosome Aberrations; Chromosomes, Human, Pair 13; GTPase-Activating Proteins; Homozygote; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; MicroRNAs; RNA; Sequence Deletion; Translocation, Genetic	2023

Article

Year

A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions.

Cancer genetics, 2023, Volume: 272-273

Topics: Chromosome Aberrations; Chromosomes, Human, Pair 13; GTPase-Activating Proteins; Homozygote; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; MicroRNAs; RNA; Sequence Deletion; Translocation, Genetic

2023